| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.18 | 0.003 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |